A detailed history of Forsta Ap Fonden transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 36,400 shares of BMRN stock, worth $2.43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,400
Previous 33,000 10.3%
Holding current value
$2.43 Million
Previous $2.72 Million 5.82%
% of portfolio
0.02%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$69.02 - $93.84 $234,668 - $319,056
3,400 Added 10.3%
36,400 $2.56 Million
Q2 2024

Aug 08, 2024

SELL
$74.43 - $92.22 $245,619 - $304,326
-3,300 Reduced 9.09%
33,000 $2.72 Million
Q1 2024

May 07, 2024

BUY
$83.81 - $99.0 $335,240 - $396,000
4,000 Added 12.38%
36,300 $3.17 Million
Q4 2023

Feb 06, 2024

SELL
$76.22 - $98.51 $396,344 - $512,252
-5,200 Reduced 13.87%
32,300 $3.11 Million
Q3 2023

Oct 25, 2023

BUY
$85.07 - $94.48 $59,548 - $66,136
700 Added 1.9%
37,500 $3.32 Million
Q2 2023

Aug 03, 2023

SELL
$86.68 - $100.3 $34,672 - $40,120
-400 Reduced 1.08%
36,800 $3.19 Million
Q1 2023

Apr 21, 2023

SELL
$87.74 - $117.27 $526,440 - $703,620
-6,000 Reduced 13.89%
37,200 $3.62 Million
Q4 2022

Feb 02, 2023

BUY
$80.93 - $108.63 $679,812 - $912,492
8,400 Added 24.14%
43,200 $4.47 Million
Q3 2022

Oct 17, 2022

BUY
$82.16 - $96.94 $829,816 - $979,094
10,100 Added 40.89%
34,800 $2.95 Million
Q2 2022

Aug 11, 2022

SELL
$71.48 - $86.85 $3.13 Million - $3.8 Million
-43,800 Reduced 63.94%
24,700 $2.05 Million
Q1 2022

May 09, 2022

BUY
$74.28 - $92.69 $4.25 Million - $5.3 Million
57,200 Added 506.19%
68,500 $5.28 Million
Q4 2021

Feb 11, 2022

SELL
$71.72 - $91.47 $2.13 Million - $2.72 Million
-29,700 Reduced 72.44%
11,300 $998,000
Q3 2021

Nov 10, 2021

SELL
$74.77 - $85.47 $2.46 Million - $2.81 Million
-32,900 Reduced 44.52%
41,000 $3.17 Million
Q2 2021

Aug 12, 2021

BUY
$75.51 - $84.79 $453,060 - $508,740
6,000 Added 8.84%
73,900 $6.17 Million
Q1 2021

May 11, 2021

BUY
$74.73 - $90.69 $2.56 Million - $3.1 Million
34,200 Added 101.48%
67,900 $5.13 Million
Q4 2020

Feb 09, 2021

SELL
$72.61 - $90.2 $261,396 - $324,720
-3,600 Reduced 9.65%
33,700 $2.96 Million
Q3 2020

Oct 22, 2020

BUY
$71.87 - $131.03 $668,391 - $1.22 Million
9,300 Added 33.21%
37,300 $2.84 Million
Q2 2020

Aug 11, 2020

BUY
$79.55 - $124.22 $159,100 - $248,440
2,000 Added 7.69%
28,000 $3.45 Million
Q1 2020

May 04, 2020

BUY
$71.37 - $96.85 $1.86 Million - $2.52 Million
26,000 New
26,000 $2.2 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.